1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Needle-Free Delivery Technology Market Analysis, By Type
5.1. Introduction
5.2. Powder Injection
5.3. Liquid Injection
5.4. Depot Injection
6. Needle-Free Delivery Technology Market Analysis, By Geography
6.1. Introduction
6.2. North America
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
6.2.4. Others
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.3.3. Others
6.4. Europe
6.4.1. United Kingdom
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.5. Middle East and Africa
6.5.1. Saudi Arabia
6.5.2. Israel
6.5.3. Others
6.6. Asia Pacific
6.6.1. Japan
6.6.2. China
6.6.3. India
6.6.4. Indonesia
6.6.5. Taiwan
6.6.6. Thailand
6.6.7. Others
7. Competitive Intelligence
7.1. Competitive Benchmarking and Analysis
7.2. Recent Investment and Deals
7.3. Strategies of Key Players
8. Company Profiles
8.1. 3M Company
8.2. Antares Pharma, Inc.
8.3. Penjet Corporation
8.4. National Medical Products, Inc.
8.5. AcuShot™ Inc.
8.6. Crossject SA
8.7. INJEX Pharma GmbH
8.8. Aradigm Corporation
8.9. Transdermal Specialties Inc.
8.10. UCB S.A., Belgium
8.11. Vaxxas, Inc.